Q4
Sales and Marketing/ Views & Analysis/ Views and analysis
Q4 results roundup 2019
Richard Staines
AbbVie, AstraZeneca, GSK, Mylan, Novartis, Pfizer, Q4, Roche, Teva
0 Comment
X
Mylan reports lower than expected earnings
https://pharmaphorum.com/news/mylan-reports-lower-than-expected-earnings/
News/ News/ Sales and Marketing
Sanofi expects growth as rare disease drugs boost earnings
George Underwood
financial results, Genzyme, Q4, Sanofi
0 Comment
X
Sanofi expects growth as rare disease drugs boost earnings
https://pharmaphorum.com/news/sanofi-expects-growth-as-rare-disease-drugs-boost-earnings/